Level of TNF-α, sTNF-RI and 8-isoprostane in the combined therapy of lacidipine and candesartan at overweight hypertensive patients
| dc.contributor.author | Ashcheulova, Tetyana | |
| dc.contributor.author | Kovalyova, Olga | |
| dc.contributor.author | Gerasimchuk, Nina | |
| dc.date.accessioned | 2016-11-17T13:00:18Z | |
| dc.date.available | 2016-11-17T13:00:18Z | |
| dc.date.issued | 2016-05 | |
| dc.description.abstract | One of the manifestations of the pathogenesis of such combined pathology as hypertension (AH) and obesity is the development of endothelial dysfunction (ED). Recent studies suggest a possible role of immune-inflammation activation mediated by pro-inflammatory cytokines, and oxidative stress (OS) in the development of ED. | ru_RU |
| dc.identifier.citation | Ashcheulova T. V. Level of TNF-α, sTNF-RI and 8-isoprostane in the combined therapy of lacidipine and candesartan at overweight hypertensive patients / T. V. Ashcheulova, O. N. Kovalyova, N. N. Gerasimchuk // Кардиология на перекрестке наук : VII Международный конгресс совместно с XI Международным симпозиумом по эхокардиографии и сосудистому ультразвуку, ХXIII ежегодной научно-практической конференцией «Актуальные вопросы кардиологии», Н. Новгород, 11–13 мая 2016 г. : тезисы докладов / Филиал НИИ кардиологии «Тюменский кардиологический центр». – Н. Новгород, 2016. – С. 3. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/14593 | |
| dc.language.iso | en | ru_RU |
| dc.subject | TNF-α | ru_RU |
| dc.subject | sTNF-RI | ru_RU |
| dc.subject | 8-isoprostane | ru_RU |
| dc.subject | arterial hypertension | ru_RU |
| dc.subject | lacidipine | ru_RU |
| dc.subject | candesartan | ru_RU |
| dc.title | Level of TNF-α, sTNF-RI and 8-isoprostane in the combined therapy of lacidipine and candesartan at overweight hypertensive patients | ru_RU |
| dc.type | Thesis | ru_RU |